secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001641172-25-008878
Event type: litigation
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals settles lawsuit with 62,500 shares, gets $100k loan from CEO trust at 18%
--------------------------------------------------------------------------------

- Entered settlement with 1800 Diagonal Lending, issuing 62,500 restricted shares to dismiss lawsuit with prejudice (May 5, 2025).
- Borrowed $100,000 from The Tiger Cub Trust (CEO-controlled) via 18% promissory note maturing May 2, 2026.
- Two Series B Preferred conversions: 100 shares for 73,333 common (Apr 28) and 300 shares for 220,000 common (May 1).
- Outstanding common shares now 11,034,023 after settlement and conversion issuances.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000164117225008878/0001641172-25-008878-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000164117225008878/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-008878

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer